Petros Pharmaceuticals (NASDAQ:PTPI) just reported results for the second quarter of 2024. Petros Pharmaceuticals reported earnings per share of -37 cents. This was above the analyst estimate for EPS ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback